Comparison | MD (%)a | CV (%)a | sMDa,b | sSEMa,b | ICCr a | r s a | SDDa (%) |
---|---|---|---|---|---|---|---|
tr1; s2-1 | −5.70 | 5.65 | −0.31 ± 0.11 | 0.31 | .91 | .89* | 15.65 |
tr1; s3-2 | −0.51 | 4.52 | −0.03 ± 0.08 | 0.24 | .95 | .94* | 12.52 |
tr2; s2-1 | −3.61 | 4.77 | −0.20 ± 0.12 | 0.27 | .93 | .95* | 13.21 |
tr2; s3-2 | −0.36 | 4.13 | −0.02 ± 0.09 | 0.22 | .95 | .96* | 11.44 |
tr3; s2-1 | −3.44 | 4.54 | −0.19 ± 0.11 | 0.25 | .94 | .94* | 12.58 |
tr3; s3-2 | −0.38 | 3.56 | −0.02 ± 0.08 | 0.20 | .96 | .96* | 9.86 |
mtr1-3; s2-1 | −4.32 | 4.28 | −0.24 ± 0.10 | 0.24 | .95 | .94* | 11.86 |
mtr1-3; s3-2 | −0.42 | 3.34 | −0.02 ± 0.08 | 0.21 | .97 | .96* | 9.25 |
mtr1-2; s2-1 | −4.69 | 4.89 | −0.26 ± 0.11 | 0.27 | .93 | .92* | 13.55 |
mtr1-2; s3-2 | −0.44 | 3.78 | −0.02 ± 0.09 | 0.20 | .96 | .95* | 10.47 |
mtr2-3; s2-1 | −3.56 | 4.14 | −0.20 ± 0.10 | 0.24 | .95 | .95* | 11.47 |
mtr2-3; s3-2 | −0.37 | 3.36 | −0.02 ± 0.08 | 0.18 | .97 | .96* | 9.31 |
besttr1-3; s2-1 | −2.64 | 3.90 | −0.15 ± 0.14 | 0.22 | .96 | .96* | 10.80 |
besttr1-3; s3-2 | −0.27 | 3.15 | −0.01 ± 0.11 | 0.17 | .97 | .98* | 8.73 |
besttr1-2; s2-1 | −3.67 | 4.48 | −0.20 ± 0.12 | 0.25 | .94 | .95* | 12.41 |
besttr1-2; s3-2 | −0.35 | 3.84 | −0.02 ± 0.10 | 0.21 | .96 | .96* | 10.64 |
besttr2-3; s2-1 | −2.45 | 4.06 | −0.14 ± 0.11 | 0.23 | .95 | .95* | 11.24 |
besttr2-3; s3-2 | −0.23 | 3.13 | −0.01 ± 0.09 | 0.17 | .97 | .97* | 8.67 |